In vitro, quantitative sandwich ELISA assay for the measurement of SARS-CoV-2 nucleocapsid protein in serum, cell culture supernatant and other biological samples.
This ELISA Kit utilizes ATGC's proprietary Biologically labeled Ultra-sensitive (BioUltra) antibody for the detection without the use of any chemically conjugated secondary antibodies. The assay requires only one wash step and can be completed within 90 minutes. An antibody specific for SARS-CoV-2 nucleocapsid protein has been pre-coated onto a microplate. Standards and samples are pipetted into the wells together with the BioUltra detection antibody. Any SARS-CoV-2 nucleocapsid protein present forms a complex with the detection antibody and immobilizes to the wells by the coated antibody. Following incubation unbound samples are removed by washing. Then a substrate reagent is added and the luminescent signal is measured with a plate reader. A standard curve is prepared from seven standard dilutions and the SARS-CoV-2 nucleocapsid protein concentration in the sample is determined.
|BioUltra SARS-CoV-2 Nucleocapsid ELISA Kit
Antibody coated microplate (12 x 8-well strips)
500x Detection antibody (30 uL)
Recombinant SARS-CoV-2 nucleocapsid protein standard (300 uL, 16 ng/mL in 1x Sample diluent)
Substrate (5 mL)
2x Sample diluent (10 mL)
10x Wash buffer (30 mL)
|Measurement of SARS-CoV-2 nucleocapsid protein in serum, cell culture supernatant and other biological samples.
|-20C to +4C (see product datasheet)
If you publish research with this product, please let us know so we can cite your paper.